Chemistry: molecular biology and microbiology – Vector – per se
Patent
1994-10-12
2000-11-28
Chambers, Jasemine
Chemistry: molecular biology and microbiology
Vector, per se
435455, 435 691, 800 18, C12N 1563, C12N 1500, C12N 1509, C12N 500
Patent
active
061534277
ABSTRACT:
An erythropoietin-inducible, erythroid-specific DNA construct is disclosed. The DNA construct comprises a promoter sequence from a sheep juvenile beta globin gene, an erythroid-specific enhancer sequence from the locus control region of the human beta globin gene and a nucleotide coding sequence of interest.
REFERENCES:
patent: 5126260 (1992-06-01), Tuan et al.
R. Behringer et al. Science 245 : 971-3 ('89).
T. Friedmann, Science 244 : 1275-81 ('89).
A. Miller Nature 357 : 455-60 ('92).
A. Miller Blood 76(2) : 271-8 ('90).
J. Chang et al. PNAS 89:3107-10 ('92).
S. McCure et al. N.A.R. 22(21) 4477-81 ('94).
M. Kay et al. 71G 10(7) ('94) 253-7.
R. Milligan Science 260: 926-32 ('93).
NIH Report on Gene Therapy/S.Orkin & A. Motulsky, co-chairs, Dec. 7, 1995.
Houdebine, Journal of Biotechnology, vol. 34, pp. 269-287., 1994.
Cowie et al., Molecular and Cellular Biology, vol. 8, No. 8, pp. 3122-3128, Aug. 1988.
Yu et al., The Journal of Biological Chemistry, vol. 266, No. 14, pp. 8907-8915, 1991.
Schmidt-Wolf et al., Journal of Hematotherapy, vol. 4, pp. 551-561.
King Donna
Schneider Gary B.
Chambers Jasemine
Martin Jill D.
Northeastern Ohio Universities College of Medicine
LandOfFree
Erythropoietin-inducible, erythroid-specific DNA construct does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Erythropoietin-inducible, erythroid-specific DNA construct, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythropoietin-inducible, erythroid-specific DNA construct will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1724054